Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin vs. Atorvastatin/Ezetimibe in Statin Hypo-responders
NCT00965055Phase 3Terminated
- Sponsor
- University of California, San Diego
- Start
- Sep 2009
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ezetimibe in hypercholesterolemia, sponsored by University of California, San Diego. Started Sep 2009; status: terminated.
02
Drugs
ezetimibe
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00965055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00965055.